NCT01721447View on ClinicalTrials.gov

Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Atrial Fibrillation
Interventions
DRUG

Optison echocardiography contrast agent

Subjects undergoing transesophageal echocardiography who will receive the Optison contrast agent during the procedure to test if the image quality improves to provide accurate assessment of the presence of left atrial thrombus.

Trial Locations (1)

84132

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT01721447 - Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage | Biotech Hunter | Biotech Hunter